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Abstract: 
Interferon (IFN)-τ secreted only by ruminant endometrium, helps in maternal recognition of pregnancy and exhibit antiviral and 
antiproliferative activity. Among different types of IFN-τ, IFN-τ1c and IFN- τ3a are the most highly expressed isoforms. In the present 
study structure of INF-τ1c was predicted using homology modelling. The best model was selected based on overall stereo-chemical quality. 
The generated 3D structure of the Interferon-τ1c protein of Bos taurus was predicted using the ovine interferon-τ (PDB ID: 1B5L_A) as 
template. The structure comprises of 5 α helices separated by loop regions, which is similar to the one predicted for other IFNs. Molecular 
interactions of bovine IFN-τ1c with human interferon Type 1 receptor (IFNAR1) was explored in an attempt to predict human IFNAR1 
binding sites of IFN-τ1c.  
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Background: 
The Interferon (IFN)-τ a member of Type I IFN, produced by 
ruminant ungulates, during blastocyst stage and the time when the 
elongated trophoblast attaches to the uterine wall, prevents the 
destruction of the corpus luteum and helps in maternal recognition 
of pregnancy. IFN-τ acts on the endometrium to abrogate 
production of luteolytic pulses of PGF2α, produced from the uterine 
endometrium [1-4] by reducing expression of estrogen and oxytocin 
receptors in uterine epithelial cells [5, 6]. Transcriptional 
inactivation of the Cox-2 gene from uterine epithelial cells, upon 
exposure to IFN- τ has also been suggested [7]. IFN-τ has potent 
antiviral [8] and antiproliferative activity [9,10] like other IFNs, but 
is less toxic in vitro and in vivo than IFN-α and IFN-β [11, 12], 
moreover they are unique in that, these responses are not induced by 
viral infection [2] , and could therefore be considered a possible 
alternative to IFN-α. IFN-τ also inhibits human and feline 
immunodeficiency virus replication [13, 14]
 without cytotoxicity, 
and its anti-HIV effects in human macrophages are stronger than 
those of IFN-α2a [13]. IFN-τ induces the same antiviral pathways in 
macrophages as other type I IFNs but without associated toxicity 
[15]. This is important since the type I IFNs are potent therapeutic 
agents for the treatment of various diseases, moreover preventing 
the infection of macrophages and the production of viral particles in 
these cells might make it possible to control the spread of HIV to 
some extent. 
 
Bovine IFN-τ, like IFN-α, IFN-β and IFN-ω belong to type I IFNs, 
and possess many common features. IFN-τ exhibit nearly 70 and 
50% homology to IFN-ω and IFN-α (166-residue), respectively. On 
the basis of secondary and tertiary structure predictions, all IFN 
subtypes probably fold in a roughly similar manner and have the 
same general overall architecture based on five α-helices separated 
by loop regions [16].  The INF-τ family can be further sub-divided 
into 3 major groups. Out of different bovine isoforms of INF-τ 
expressed during blastocyst stage, there is a major bias for 
expression of IFN-τ1c and INF-τ3a  [17]. In the present paper 
homology based modelling was used to predict the protein model 
and potential binding sites of IFN-τ1c.  
 
In case of humans all, type I IFNs (α, β and ω) bind to IFN receptor 
(IFNAR) which consists of two subunits, IFNAR-1 and IFNAR-2. 
IFNAR-2 binds to all types 1 IFNs with lower affinity and has 
different specificity as compared to IFNAR complex where as 
IFNAR-1 exhibit low intrinsic binding of IFNs but strongly affects 
the affinity and differential ligand specificity of the IFNAR 
complex [18]. Hence the molecular interaction of the IFNAR1 with 
bovine INF-τ1c was carried out to predict its interaction with the 
human IFNAR complex.  
 
Methodology: 
Sequence retrieval: 
The structural template protein, which is the structural homologue 
of the target protein i.e. INF-τ1c from Bos taurus, was identified in 
NCBI (www.ncbi.nlm.nih.gov/) using protein Basic Loci Alignment 
Search Tool (pBLAST) [19] and Protein Data Bank (PDB) [20] was 
set as reference data base. 
 
Structure Prediction and Evaluation: 
Modeller 9v5 [21] was used for alignment of target protein 
sequence (INF-τ1c) with its corresponding template (1B5L) with 
the help of align 2D module. The target sequence file and the file 
containing the structural coordinates of template, in the PIR (Protein 
Information Resource) format were generated, which are essential 
for identification of the common conserved sequences and to know 
about the active residues in both the sequences. The 3D structure 
was predicted based on spatial constraints.  
 
Models generated were subjected to Swiss PDB viewer [22] for 
minimisation of energy, using the steepest descent conjugate 
gradient technique to eliminate the unfavourable contacts between 
protein and H2O molecules and to correct the stereochemistry of the 
model. Computational analysis was carried out  in vacuo with 
GROMOS96 43B1 parameters set, without reaction field in Swiss 
PDB viewer. The refined model was subjected to a series of tests for 
validation of consistency and reliability of the model using 
PROCHECK_NT  [23]. Backbone structure of the protein was 
obtained by the assessment of χ/ψ plots. SAVS NIH (http://nih 
server.mbi.ucla.edu/SAVES/) was used to explore the non bonded 
interactions between different atom types.  
 
Molecular interaction: 
INF-τ1c predicted model was docked to human IFNAR1 using Hex 
5.1  (http: //www.csd.abdn.ac.uk/hex/). The atomic coordinates of 
human IFNAR1 was retrieved from PDB (PDB ID: 1N6V) [20]. For 
identification of pockets present on IFNAR1, Ligsite CSC (Conally 
Surface and Degree of Conservation) software 
(www.scoppi.biotech.tu-dresden.de/pocket/) was used. Ligsite uses 
grids to detect functional sites, further, conally surfaces and degree 
of conservation are used for refining. Different pockets of the 
receptor were obtained and arranged according to their volumes. 
The pocket having the maximum surface area was selected and the 
nearest atom to the pocket was determined using the distance tool in 
Swiss PDB viewer. Only this pocket was used for binding in further 
steps. Introduction of ligand into pocket was done using Hex 5.1. A 
pocket is the functionality centre of protein and has no physical 
existence in 3 dimensional spaces. To place a ligand in the pocket 
with maximum interaction, indirect approach was applied. Placing 
of ligand into the cavity should be such that the Vander Waal’s radii 
of the ligand and electron cloud of the closest atom to pocket do not 
overlap. Parameters, such as receptor and ligand angle, twist angle, 
steric scan were changed to bring the ligand close to the closest 
atom of the pocket. Before docking all hetero molecules like ions 
and water molecules were removed using Hex. 
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Discussion: 
The amino acid sequence of the Bos taurus INF-τ1c (accession 
number: AAF08671) protein was retrieved from the SWISS PROT 
(http://www.expasy.org). The molecular weight of the protein is 
19.79 KDa and its pI is 6.01 which were obtained from Sequence 
Manipulation Suite (http://www.bioinformatics.org/sms2/). The 
template file exhibited a sequence similarity of 80%. The target and 
template protein alignment was performed using ClustalW for 
determining the conserved regions (Figure 1).  
 
After alignment, 20 different models were generated using Modeller 
9v5, out of them best 5 were selected. The selected models were 
then subjected to energy minimisation using SWISS PDB viewer. 
The model with the lowest objective function (-10029.48), was 
selected and subjected to quality evaluation. Ramachandran plot of 
the model was obtained using PROCHECK_NT, out of total, 94.2% 
of the residues were in the favourable region, 5.2% in additional 
allowed regions, 0.6% in generously allowed regions and 0.0% in 
disallowed regions. The quality factor of protein model was 87.5% 
which was obtained using SAVS NIH 
(nihserver.mbi.ucla.edu/SAVES). 
 
The model was then submitted to protein model data base 
(PM0075822) (http://mi.caspur.it). The visualisation of the 3D 
structure of protein was done with the help of PyMol software. The 
generated model was found to contain 5 α helices separated by loop 
regions, as reported earlier for other members of Type I IFN family. 
The high level of structural similarity, of different members of IFN-
τ family, and among different species indicates the significance and 
conservation of their function.   
 
Based on rigid-body docking using HEX 5.1, both proteins were 
analyzed for shape complementary and electrostatic interactions 
(Figure 2). Two pockets (pkt 87 & pkt 19) of IFNAR1 were 
obtained from Ligsite. Pkt 87 was chosen as it was having the 
maximum surface area and volume. Also from the Swiss PDB 
viewer, residue Arg 73 with atom ‘C-alpha’, having distance 5.06Å 
was found to be the closest to the pocket.  It was found that keeping 
ligand and receptor angle at 45˚, twist angle at 180˚ and steric scan 
at 15, ligand was closest to the pocket and total energy was -370.15. 
These docking results indicated that the complex (figure 2) could be 
stabilized by hydrogen bonding.  
 
Type I IFNs induce the synthesis of antiviral factors via activation 
of the cellular Jak-STAT signalling pathway. There are three main 
mechanisms involving 2’, 5’-oligoadenylate synthetase (2’, 5’-
OAS), RNA-dependent serine-threonine kinase R (PKR) and MxA 
protein. 2’,5’-OAS activated by the TAR sequence on human 
immunodeficiency virus (HIV) RNA, activates the latent RNase L. 
The 2’, 5’-OAS/RNase L pathway was found to be involved in 
inhibiting HIV. The second factor PKR, is known to impair HIV 
replication in chronically infected cells, and the third, MxA protein 
of the GTPase superfamily has been proposed to act at different 
levels of the virus replication cycle, as for other viruses [15]. The 
potential binding of the IFN-τ1c protein with the human IFNAR1 
may illicit the same response as reported earlier for ovine 
recombinant IFN-τ. Though production of recombinant bovine IFN-
τ1c has never been reported, other members of bovine INF have 
been produced but their efficacy as anti-viral or anti-HIV agents has 
never been explored.   
 
 
Figure 1: Sequence alignment of target and template proteins generated by clustalW 
 
 
Figure 2: Molecular interaction between IFNAR1 & INF-τ1c Bioinformation    open access 
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Conclusion 
Structure of INF-τ1c was predicted using homology modelling, 
which is basically similar to other INFs and the crystallized murine 
IFN-β [24]. Proper understanding of the structure, may not only add 
on to the current understanding of functioning but also differences 
within closely related proteins of the same family. IFN-τ is 
structurally different from other IFNs (α, β and ω), biologically they 
constitute a distinct serological group, and also differ considerably 
in amino acid sequence. Also they are much less toxic than other 
INFs. This suggests that IFN-τ may present themselves in a distinct 
manner, to the receptors on the uterine endometrium and other 
potentially functional sites, as compared to other IFNs. A 
comparison between the structure and amino acid residues in the 
potential binding site may provide a clue to these differential 
properties. Here we have shown that bovine IFN-τ1c interact with 
the human IFNAR1 and therefore may bind to the human IFNAR, 
thus activating its downstream signalling molecules. Ability of 
ovine IFN-τ has been previously shown to exhibit resistance to 
HIV-1 infection in human macrophages [15]. Thus it will be 
exciting to explore the antiviral activity of bovine IFN-τ1c.  
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